Immunogenic neoantigens derived from gene fusions stimulate T cell responses

By Wei Yang, Ken-Wing Lee, Raghvendra M Srivastava, F. Kuo, C. Krishna, D. Chowell, V. Makarov, Douglas R. Hoen, M. Dalin, L. Wexler and 24 more. 2019

Subfields: Cancer Research, Genetics, Immunology

Citations in the corpus

• Case Report: “DEK::AFF2 fusion associated sinonasal carcinomas: a novel oncogenic driver and emerging therapeutic strategies” (2025, unknown): “Notably, this response occurred following disease progression under prior treatment with platinum-based chemotherapy and 5-fl uorouracil, which failed to achieve disease control after one year (7).”